University of Health Sciences (Sağlık Bilimleri Üniversitesi)
Istanbul, 34668, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07070843
This study was designed as a prospective, randomized controlled experimental study aiming to compare different approaches to eye care in intensive care patients receiving mechanical ventilation. In this study, patients receiving mechanical ventilation in the intensive care unit will be randomly assigned to four groups using a simple randomization method:
1. Control Group: Standard Eye Care 2. Intervention Group 1: Eye Care with Eye Care Kit 3. Intervention Group 2: Eye Care According to Eye Care Protocol 4. Intervention Group 3: Eye Care with Both Protocol and Eye Care Kit Research Hypotheses H1: Eye care provided using a care protocol is more effective in preventing the development of complications compared to standard eye care.
H2: Eye care provided using an eye care kit is more effective in preventing the development of ocular complications compared to standard eye care.
H3: The combined use of an eye care kit and a care protocol is more effective in preventing the development of ocular complications compared to using the care protocol alone.
H4: The use of an eye care kit is more effective in preventing the development of ocular complications compared to the use of a care protocol.
Interested in participating?
Request Info18 day and older
All sexes
Interventional
Not applicable
Istanbul, 34668, Turkey (Türkiye)
Location status: Recruiting
Study Design and Methodology
In this study, patients receiving mechanical ventilation support in the intensive care unit will be randomly assigned to four groups using a simple randomization method:
Patients will be assessed daily for signs of infection and conjunctival edema as per the protocol. Any signs of infection or complications will be marked with a (+) on the form.
Evaluation and Analysis During the study period, all patient groups will be assessed at specific intervals for ocular complications (conjunctival edema, eye infections, and dry eye). The effectiveness of the interventions will be measured accordingly. Clinical observation, the Schirmer test, and necessary laboratory/imaging methods will be used for the assessment of ocular complications.
Inter-group differences will be statistically analyzed based on pre-defined dependent variables. The study aims to evaluate whether the use of the eye care protocol and/or the eye care kit provides superior outcomes compared to standard care in the prevention of complications.
The Schirmer test will be administered to both eyes on the first day (prior to the first eye care intervention), as well as on the fifth, seventh, and tenth days after eye care is performed. Signs and symptoms of eye infection and chemosis will be evaluated daily after the second eye care procedure. Data for all group will be collected, and the administration and documentation of eye care will be monitored.
Study Variables Dependent Variables: Conjunctival edema, eye infections, and dry eye observed in ICU patients.
Independent Variables: Age, gender, diagnosis, comorbidities, Glasgow Coma Scale score, use and type of sedation, use and type of muscle relaxants, use and type of antibiotics, duration of mechanical ventilation, ventilator mode, ambient humidity level, blinking frequency, eyelid closure level, albumin levels, Schirmer test results, and use of the eye care kit.
Sample Size The study population will consist of all patients who are connected to mechanical ventilators for diagnosis, treatment, or follow-up and are admitted to the Anesthesia and Reanimation Intensive Care Units of Kartal Dr. Lutfi Kırdar City Hospital, which operates under the Istanbul Provincial Health Directorate.
To determine the required sample size, a power analysis was conducted using the G*Power software (version 3.1.9.4). The power of the study is expressed as 1-β (where β represents the probability of a Type II error). Based on the Chi-square test for independent groups: Goodness-of-fit tests - Contingency tables, and assuming an effect size of d = 0.58 for the secretion variable, the analysis indicated that a minimum of 39 participants per group is required.
Randomization Method After identifying patients who meet the inclusion criteria, they will be randomly assigned to the intervention and control groups. The randomization process will be conducted using a computer-based random number generator (e.g., Excel's RAND() function or tools such as random.org). This approach ensures independence and balance between groups.
Data Collection Tools Data will be collected using the Patient Identification Form, the Glasgow Coma Scale, the "Eye Care Protocol" developed by Ayfer Hiçerimez in 2024 for intensive care unit (ICU) patients, and the Schirmer Test to assess ocular dryness. Eye care interventions will be implemented based on the "Eye Care Kit Application Procedure" developed by the researcher.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Withdrawal Criteria:
There is no established protocol or guideline for eye care in the intensive care unit where the study will be conducted. Routine eye care involves the use of sterile gauze and sterile saline. During routine suctioning procedures, patients' eyes are not closed. If a patient is unable to achieve full eyelid closure, their eyes are covered with an eye patch or sterile gauze. The Schirmer test will be administered to both eyes on the first day (prior to the first eye care intervention), as well as on the fifth, seventh, and tenth days after eye care is performed. Signs and symptoms of eye infection and chemosis will be evaluated daily after the second eye care procedure. Data for this group will be collected, and the administration and documentation of eye care will be monitored.
Eye care will be performed using an eye care kit. All nursing staff in the intensive care unit will receive training regarding the contents and usage of the kit. Patients in this group will receive eye care solely using the kit, following a 4-times-daily care protocol. For patients with lagophthalmos, eyes will be covered using the eye closure pad provided in the kit. The Schirmer test will be performed on both eyes on the first day prior to the initial eye care intervention, and on the fifth, seventh, and tenth days following eye care, with results recorded. Signs of infection and chemosis will be assessed daily after the second eye care session. Data collection will be done using , and eye care administration will be tracked.
Time frame: Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.
Conjunctival Edema (Chemosis): Chemosis is the edema of the conjunctiva, which is a thin, transparent membrane covering the inner surface of the eyelids and the white part of the eyes (sclera). It refers to the swelling of this membrane that lines the ocular surface.
Time frame: Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.
Signs and Symptoms of Ocular Infection: Redness, ocular discharge, crusting along the eyelid margins, adhesion of eyelashes (eyelashes sticking together), corneal discoloration (loss of corneal transparency), periorbital edema.
Time frame: Data collection was conducted for 10 consecutive days, beginning 24 hours after admission to the intensive care unit.
Dry Eye: Dry eye is a multifactorial disease of the ocular surface, defined by tear film instability and associated with symptoms including ocular discomfort, burning sensation, irritation, dryness, visual blurring, and foreign body sensation."
Contact information is provided by the study sponsor or research team.
Besey Oren
CONTACT
Yildiz Deniz
CONTACT
Istanbul Saglik Bilimleri University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07227714
Cataract Surgery, Eye Care
San Francisco, California, United States
View Trial DetailsNCT00591110
Eye Care, Eye Disease
Birmingham, Alabama, United States
View Trial DetailsNCT07715682
Female Urogenital Diseases and Pregnancy Complications, Neonatal Intensive Care Unit
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07516249
Distraction Methods, Nursing Care
Mersin, Turkey (Türkiye)
View Trial Details